Kiora Pharmaceuticals KPRX Income Statement (2014-2026)

NASDAQ KPRX
$2.62 +0.02 (+0.77%)
As of: Aug 20, 2026 · 3:58 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
0.03M0.03M0.04M0.04M0.09M0.08M0.21M0.37M0.85M0.54M2.92M4.17M4.21M3.87M4.22M3.43M3.43M3.76M3.99M6.18M
Revenue & cost
Revenue (Quarter)
16.00M0.02M
Operating items
Research & Development (Quarter)
1.63M1.00M0.71M0.57M1.33M0.84M0.44M1.39M1.09M1.11M0.19M1.14M0.87M0.74M2.53M1.68M1.66M1.75M2.12M2.08M
Selling, General & Administrative (Quarter)
1.34M1.38M1.66M1.80M2.03M2.78M1.27M1.10M1.42M0.88M1.30M1.54M1.38M1.33M1.49M1.35M1.44M1.46M1.61M1.38M
Restructuring Costs (Quarter)
0.96M
Other Operating Expenses (Quarter)
0.07M3.99M0.00M0.34M-0.98M3.42M0.13M1.29M-0.11M1.35M0.50M-1.69M-0.64M-2.31M4.10M-1.23M-1.25M
Operating Expenses (Quarter)
3.04M6.37M3.57M2.40M3.70M2.63M1.92M2.63M5.92M2.12M2.78M2.56M3.60M2.56M2.33M2.40M0.79M7.31M2.51M2.21M
Operating Income (Quarter)
-3.04M-6.37M-3.57M-2.40M-3.70M-2.63M-1.92M-2.63M-5.92M-2.12M13.22M-2.54M-3.60M-2.56M-2.33M-2.40M-0.79M-7.31M-2.51M-2.21M
EBIT (Quarter)
-3.04M-6.37M-3.57M-2.40M-3.70M-2.63M-1.92M-2.63M-5.92M-2.12M13.22M-2.54M-3.60M-2.56M-2.33M-2.40M-0.79M-7.31M-2.51M-2.21M
Non-operating items
Interest & Investment Income (Quarter)
259.00300.00217.000.00M
Other Non Operating Income (Quarter)
-0.28M937.00-0.02M0.01M-0.03M0.11M-0.07M0.01M-0.02M-0.06M0.10M-0.02M-0.09M-0.02M-0.03M-0.05M-0.01M
Non Operating Income (Quarter)
259.00-0.00M0.00M0.00M-1.42M0.02M0.05M0.05M0.16M0.03M0.23M0.34M0.19M0.34M0.26M0.13M0.18M0.14M0.14M0.15M
Net income details
EBT (Quarter)
-0.07M-14.39M-3.63M-2.58M-3.84M-2.52M-1.92M-2.67M-5.94M-35.14M13.45M-2.22M-3.41M-2.16M-2.07M-2.26M-0.62M-7.17M-2.42M-2.08M
Tax Provisions (Quarter)
2.07M0.12M-0.11M-0.64M-0.67M
Profit After Tax (Quarter)
-3.08M-6.18M-3.57M-2.57M-5.12M-2.59M-1.87M-2.61M-5.80M-2.27M13.45M-2.22M-3.41M-4.33M-2.19M-2.10M0.03M-6.52M-2.42M-2.11M
Income from Non-Controlling Interests (Quarter)
-0.00M0.08M-0.04M-0.02M-0.01M0.01M-0.00M-0.01M-0.01M
Income from Continuing Operations (Quarter)
-0.07M-14.39M-3.63M-2.58M-3.84M-2.52M-1.92M-2.67M-5.94M-35.14M13.45M-2.22M-3.41M-4.22M-2.19M-2.15M0.03M-6.50M-2.42M-2.08M
Consolidated Net Income (Quarter)
-0.07M-14.39M-3.63M-2.58M-5.12M-2.50M-1.92M-2.67M-6.29M-2.27M13.45M-2.22M-3.41M-4.22M-2.19M-2.15M0.03M-6.50M-2.42M-2.08M
Income towards Parent Company (Quarter)
-0.07M-14.39M-3.63M-2.58M-5.12M-2.50M-1.92M-2.67M-6.29M-2.27M13.45M-2.22M-3.41M-4.22M-2.19M-2.15M0.03M-6.50M-2.42M-2.08M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-0.07M-14.39M-3.63M-2.58M-5.12M-2.50M-1.92M-2.67M-6.29M-2.27M13.45M-2.22M-3.41M-4.22M-2.19M-2.15M0.03M-6.52M-2.42M-2.08M
Additional items
EPS (Basic) (Quarter)
-2.39-560.69-99.93-71.02-54.30-30.71-9.26-7.31-7.97-4.224.67-0.53-0.81-1.09-0.52-0.540.01-1.56-0.58-0.34
EPS (Diluted) (Quarter)
-2.39-560.69-99.93-71.02-54.30-30.71-9.26-7.31-7.97-4.223.46-0.53-0.81-1.02-0.52-0.540.01-1.59-0.58-0.34
Shares Outstanding (Quarter)
0.03M0.03M0.04M0.04M0.09M0.08M0.21M0.37M0.79M0.54M2.88M4.17M4.21M3.87M4.22M3.99M4.29M4.17M4.17M6.18M
Shares Outstanding (Diluted) (Quarter)
0.03M0.03M0.04M0.04M0.09M0.08M0.21M0.37M0.79M0.54M3.89M4.17M4.21M4.13M4.22M3.99M4.36M4.10M4.17M6.18M
EBITDA (Quarter)
-3.04M-6.37M-3.57M-2.40M-3.70M-2.63M-1.92M-2.63M-5.92M-2.12M13.22M-2.54M-3.60M-2.56M-2.33M-2.40M-0.79M-7.31M-2.51M-2.21M
Interest Expenses (Quarter)
0.03M-0.10M0.06M0.18M0.14M-0.11M785.000.04M0.02M33.03M0.01M0.09M0.01M13.14M0.01M0.04M0.03M1.000.02M0.35M
Tax Rate (Quarter)
-95.67-5.944.95104.359.32